DNA alkylation and interstrand cross-linking by treosulfan
1999
How treosulfan works against cancer
publication
Author Information
Author(s): Hartley J A, O'Hare C C, Baumgart J
Primary Institution: CRC Drug–DNA Interactions Research Group, Department of Oncology, UCL Medical School
Hypothesis
The conversion of treosulfan is required for cytotoxicity in vitro.
Conclusion
Treosulfan treatment leads to DNA alkylation and interstrand cross-linking, which are important for its anti-tumor effects.
Supporting Evidence
- Treosulfan converts to epoxy compounds that are necessary for its anti-tumor activity.
- DNA alkylation occurs at guanine bases, similar to other alkylating agents.
- Cross-links in K562 cells peak at approximately 24 hours after treatment.
Takeaway
Treosulfan is a medicine that helps fight cancer by changing into a form that can stick to DNA and stop cancer cells from growing.
Methodology
The study observed DNA alkylation and cross-linking in K562 cells after treosulfan treatment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website